Last reviewed · How we verify
NCT03141944: IMPACT
Evolution of Hypodopaminergic Syndrome in Early Parkinson's Disease
trial testing Starkstein scale of Apathy in Parkinson Disease in 90 participants. Completed in 11 March 2020.
11 March 2020
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 23 February 2017 |
| Primary completion | 11 March 2020 |
| Estimated completion | 11 March 2020 |
| Sites | 4 locations across France |
Drugs / interventions tested
- Starkstein scale of Apathy
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
- Apathy — all drugs for Apathy →
Sponsor
University Hospital, Grenoble
Who can join
Adults 33 to 72, any sex, with Parkinson Disease or Apathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to describe the evolution of hypodopaminergic syndrome in patients with Parkinson's disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Improvement of apathy in early Parkinson's disease.
Castrioto A, Schmitt E, Anheim M, Meoni S, et al · · 2025 · cited 1× · PMID 40274806 · DOI 10.1038/s41531-025-00937-w
Verify or expand the search:
- PubMed search for NCT03141944
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03141944 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 29 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03141944.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing